Skip to main content
Top
Published in: BMC Gastroenterology 1/2014

Open Access 01-12-2014 | Research article

Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease

Authors: Rohini Mehta, Aybike Birerdinc, Lei Wang, Zahra Younoszai, Amir Moazzez, Hazem Elariny, Zachary Goodman, Vikas Chandhoke, Ancha Baranova, Zobair M Younossi

Published in: BMC Gastroenterology | Issue 1/2014

Login to get access

Abstract

Background

Stomach is an integral part of the energy balance regulating circuit. Studies exploring the effects of cross-system changes in the energy homeostasis in stomach tissue are scarce. The proximity of the stomach to liver - the most common secondary target affected by obesity – suggests that these two organs are exposed to each other’s local secretion. Therefore, we aimed at expression profiling of energy metabolism associated genes in the gastric tissue of obese non-alcoholic fatty liver disease (NAFLD) patients.

Methods

A total of 24 patients with histologically-proven NAFLD were included. In the gastric tissue, gene expression profiling of 84 energy metabolism associated genes was carried out.

Results

The accumulation of the fat in the liver parenchyma is accompanied by downregulation of genes encoding for carboxypeptidase E (CPE) and Interleukin 1B (IL1B) in the gastric mucosa of same patient. In patients with high grade hepatic steatosis, Interleukin 1 beta encoding gene with anorexigenic function, IL1B was downregulated. The levels expression of 21 genes, including ADRA2B, CNR1 and LEP were significantly altered in the gastric tissue of NAFLD patients with hepatic inflammation. There were also indications of an increase in the opioid signaling within gastric mucosa that may results in a shift to proinflammatory environment within this organ and contribute to systemic inflammation and the pathogenic processes in hepatic parenchyma.

Conclusions

We have shown differential expression of energy metabolism associated genes in the gastric tissue of obese NAFLD patients. Importantly, these gene expression profiles are associated with changes in the hepatic parenchyma as reflected in increased scores for hepatic steatosis, inflammation, fibrosis and NASH. This study suggests the complex interplay of multiple organs in the pathogenesis of obesity-related complications such as NAFLD and provides further evidence supporting an important role for gastric tissue in promoting obesity-related complications.
Appendix
Available only for authorised users
Literature
3.
go back to reference Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M: Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 2004, 18: 439-456. 10.1096/fj.03-0641rev.CrossRefPubMed Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M: Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 2004, 18: 439-456. 10.1096/fj.03-0641rev.CrossRefPubMed
4.
go back to reference Badman MK, Flier JS: The gut and energy balance: visceral allies in the obesity wars. Science. 2005, 307: 1909-1914. 10.1126/science.1109951.CrossRefPubMed Badman MK, Flier JS: The gut and energy balance: visceral allies in the obesity wars. Science. 2005, 307: 1909-1914. 10.1126/science.1109951.CrossRefPubMed
5.
go back to reference Cammisotto P, Bendayan M: A review on gastric leptin: the exocrine secretion of a gastric hormone. Anat Cell Biol. 2012, 45: 1-16. 10.5115/acb.2012.45.1.1.CrossRefPubMedPubMedCentral Cammisotto P, Bendayan M: A review on gastric leptin: the exocrine secretion of a gastric hormone. Anat Cell Biol. 2012, 45: 1-16. 10.5115/acb.2012.45.1.1.CrossRefPubMedPubMedCentral
6.
go back to reference Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature. 2001, 409: 194-198. 10.1038/35051587.CrossRefPubMed Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature. 2001, 409: 194-198. 10.1038/35051587.CrossRefPubMed
7.
go back to reference Fujimiya M, Ataka K, Asakawa A, Chen CY, Kato I, Inui A: Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides. Digestion. 2012, 85: 90-94. 10.1159/000334654.CrossRefPubMed Fujimiya M, Ataka K, Asakawa A, Chen CY, Kato I, Inui A: Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides. Digestion. 2012, 85: 90-94. 10.1159/000334654.CrossRefPubMed
8.
go back to reference Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, Sánchez-Margalet V: Role of leptin in the activation of immune cells. Mediators Inflamm. 2010, 2010: 568343-CrossRefPubMedPubMedCentral Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, Sánchez-Margalet V: Role of leptin in the activation of immune cells. Mediators Inflamm. 2010, 2010: 568343-CrossRefPubMedPubMedCentral
9.
go back to reference Baatar D, Patel K, Taub DD: The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011, 340: 44-58. 10.1016/j.mce.2011.04.019.CrossRefPubMed Baatar D, Patel K, Taub DD: The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011, 340: 44-58. 10.1016/j.mce.2011.04.019.CrossRefPubMed
10.
go back to reference Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM: Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obes Surg. 2011, 21: 1750-1757. 10.1007/s11695-011-0475-1.CrossRefPubMed Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM: Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obes Surg. 2011, 21: 1750-1757. 10.1007/s11695-011-0475-1.CrossRefPubMed
11.
go back to reference Wijngaarden MA, van der Zon GC, van Dijk KW, Pijl H, Guigas B: Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. J Cell Biol. 2013, 304: E1012-E1021. Wijngaarden MA, van der Zon GC, van Dijk KW, Pijl H, Guigas B: Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. J Cell Biol. 2013, 304: E1012-E1021.
12.
go back to reference Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, Nugent C, Gowder SJ, Younoszai Z, Collantes R, Chandhoke V, Younossi ZM: Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obes Surg. 2007, 17: 1111-1118. 10.1007/s11695-007-9187-y.CrossRefPubMed Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, Nugent C, Gowder SJ, Younoszai Z, Collantes R, Chandhoke V, Younossi ZM: Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obes Surg. 2007, 17: 1111-1118. 10.1007/s11695-007-9187-y.CrossRefPubMed
13.
go back to reference Yamaoka M, Maeda N, Nakamura S, Kashine S, Nakagawa Y, Hiuge-Shimizu A, Okita K, Imagawa A, Matsuzawa Y, Matsubara K, Funahashi T, Shimomura I: A pilot investigation of visceral fat adiposity and gene expression profile in peripheral blood cells. PLoS One. 2012, 7: e47377-10.1371/journal.pone.0047377.CrossRefPubMedPubMedCentral Yamaoka M, Maeda N, Nakamura S, Kashine S, Nakagawa Y, Hiuge-Shimizu A, Okita K, Imagawa A, Matsuzawa Y, Matsubara K, Funahashi T, Shimomura I: A pilot investigation of visceral fat adiposity and gene expression profile in peripheral blood cells. PLoS One. 2012, 7: e47377-10.1371/journal.pone.0047377.CrossRefPubMedPubMedCentral
14.
go back to reference Vrabie CD, Cojocaru M, Waller M, Sindelaru R, Copaescu C: The main histopathological gastric lesions in obese patients who underwent sleeve gastrectomy. Dicle Med J. 2010, 37: 97-103. Vrabie CD, Cojocaru M, Waller M, Sindelaru R, Copaescu C: The main histopathological gastric lesions in obese patients who underwent sleeve gastrectomy. Dicle Med J. 2010, 37: 97-103.
15.
go back to reference Gündoğan M, Çalli Demırkan N, Tekın K, Aybek H: Gastric histopathological findings and ghrelin expression in morbid obesity. Turk Patoloji Derg. 2013, 29: 19-26.PubMed Gündoğan M, Çalli Demırkan N, Tekın K, Aybek H: Gastric histopathological findings and ghrelin expression in morbid obesity. Turk Patoloji Derg. 2013, 29: 19-26.PubMed
16.
go back to reference Vernon G, Baranova A, Younossi ZM: Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011, 34: 274-285. 10.1111/j.1365-2036.2011.04724.x.CrossRefPubMed Vernon G, Baranova A, Younossi ZM: Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011, 34: 274-285. 10.1111/j.1365-2036.2011.04724.x.CrossRefPubMed
17.
go back to reference Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes. 2000, 49: 749-758. 10.2337/diabetes.49.5.749.CrossRefPubMed Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes. 2000, 49: 749-758. 10.2337/diabetes.49.5.749.CrossRefPubMed
18.
go back to reference Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002, 87: 3023-3028. 10.1210/jcem.87.7.8638.CrossRefPubMed Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002, 87: 3023-3028. 10.1210/jcem.87.7.8638.CrossRefPubMed
19.
go back to reference Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM: Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. Mediators Inflamm. 2013, 2013: 684237-CrossRefPubMedPubMedCentral Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM: Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. Mediators Inflamm. 2013, 2013: 684237-CrossRefPubMedPubMedCentral
20.
go back to reference Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003, 144: 5159-5165. 10.1210/en.2003-0870.CrossRefPubMed Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003, 144: 5159-5165. 10.1210/en.2003-0870.CrossRefPubMed
21.
go back to reference Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM: Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012, 2012: 983814-CrossRefPubMedPubMedCentral Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM: Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012, 2012: 983814-CrossRefPubMedPubMedCentral
22.
go back to reference Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr M: Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology. 2009, 49: 1375-1384. 10.1002/hep.22927.CrossRefPubMedPubMedCentral Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr M: Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology. 2009, 49: 1375-1384. 10.1002/hep.22927.CrossRefPubMedPubMedCentral
23.
go back to reference Roden M: Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond). 2005, 29: S111-S115.CrossRef Roden M: Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond). 2005, 29: S111-S115.CrossRef
24.
go back to reference Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ, McGehee RE, Fried SK, Kern PA: Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007, 92: 666-672. 10.1210/jc.2006-1303.CrossRefPubMed Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ, McGehee RE, Fried SK, Kern PA: Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007, 92: 666-672. 10.1210/jc.2006-1303.CrossRefPubMed
25.
go back to reference Turpin SM, Ryall JG, Southgate R, Darby I, Hevener AL, Febbraio MA, Kemp BE, Lynch GS, Watt MJ: Examination of ‘lipotoxicity’ in skeletal muscle of high-fat fed and ob/ob mice. J Physiol. 2009, 587: 1593-1605. 10.1113/jphysiol.2008.166033.CrossRefPubMedPubMedCentral Turpin SM, Ryall JG, Southgate R, Darby I, Hevener AL, Febbraio MA, Kemp BE, Lynch GS, Watt MJ: Examination of ‘lipotoxicity’ in skeletal muscle of high-fat fed and ob/ob mice. J Physiol. 2009, 587: 1593-1605. 10.1113/jphysiol.2008.166033.CrossRefPubMedPubMedCentral
26.
go back to reference Maksud FA, Alves JS, Diniz MT, Barbosa AJ: Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients. Eur J Endocrinol. 2011, 165: 57-62. 10.1530/EJE-11-0201.CrossRefPubMed Maksud FA, Alves JS, Diniz MT, Barbosa AJ: Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients. Eur J Endocrinol. 2011, 165: 57-62. 10.1530/EJE-11-0201.CrossRefPubMed
27.
go back to reference Gutierrez-Grobe Y, Villalobos-Blasquez I, Sánchez-Lara K, Villa AR, Ponciano-Rodríguez G, Ramos MH, Chavez-Tapia NC, Uribe M, Méndez-Sánchez N: High ghrelin and obestatin levels and low risk of developing fatty liver. Ann Hepatol. 2010, 9: 52-57.PubMed Gutierrez-Grobe Y, Villalobos-Blasquez I, Sánchez-Lara K, Villa AR, Ponciano-Rodríguez G, Ramos MH, Chavez-Tapia NC, Uribe M, Méndez-Sánchez N: High ghrelin and obestatin levels and low risk of developing fatty liver. Ann Hepatol. 2010, 9: 52-57.PubMed
28.
go back to reference Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, Loh YP: New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev. 2012, 33: 216-253. 10.1210/er.2011-1039.CrossRefPubMedPubMedCentral Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, Loh YP: New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev. 2012, 33: 216-253. 10.1210/er.2011-1039.CrossRefPubMedPubMedCentral
29.
go back to reference Jia EZ, Wang J, Yang ZJ, Zhu TB, Wang LS, Wang H, Li CJ, Chen B, Cao KJ, Huang J, Ma WZ: Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis. Mol Biol Rep. 2009, 36: 245-254. 10.1007/s11033-007-9173-4.CrossRefPubMed Jia EZ, Wang J, Yang ZJ, Zhu TB, Wang LS, Wang H, Li CJ, Chen B, Cao KJ, Huang J, Ma WZ: Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis. Mol Biol Rep. 2009, 36: 245-254. 10.1007/s11033-007-9173-4.CrossRefPubMed
30.
go back to reference Reyes TM, Sawchenko PE: Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J Neurosci. 2002, 22: 5091-5099.PubMed Reyes TM, Sawchenko PE: Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J Neurosci. 2002, 22: 5091-5099.PubMed
31.
go back to reference Kornman KS: Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr. 2006, 83: 475S-483S.PubMed Kornman KS: Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr. 2006, 83: 475S-483S.PubMed
32.
go back to reference Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001, 120: 337-345. 10.1053/gast.2001.22158.CrossRefPubMed Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001, 120: 337-345. 10.1053/gast.2001.22158.CrossRefPubMed
33.
go back to reference De Datta D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali GK, Roychoudhury S: IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One. 2011, 6: e14775-10.1371/journal.pone.0014775.CrossRef De Datta D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali GK, Roychoudhury S: IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One. 2011, 6: e14775-10.1371/journal.pone.0014775.CrossRef
34.
go back to reference Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A: Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One. 2013, 8: e53626-10.1371/journal.pone.0053626.CrossRefPubMedPubMedCentral Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A: Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One. 2013, 8: e53626-10.1371/journal.pone.0053626.CrossRefPubMedPubMedCentral
35.
go back to reference Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, Lewin MJ: The stomach is a source of leptin. Nature. 1998, 394: 790-793. 10.1038/29547.CrossRefPubMed Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, Lewin MJ: The stomach is a source of leptin. Nature. 1998, 394: 790-793. 10.1038/29547.CrossRefPubMed
36.
go back to reference Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, Laigneau JP, Attoub S, Lehy T, Henin D, Mignon M, Lewin MJ: Leptin secretion and leptin receptor in the human stomach. Gut. 2000, 47: 178-183. 10.1136/gut.47.2.178.CrossRefPubMedPubMedCentral Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, Laigneau JP, Attoub S, Lehy T, Henin D, Mignon M, Lewin MJ: Leptin secretion and leptin receptor in the human stomach. Gut. 2000, 47: 178-183. 10.1136/gut.47.2.178.CrossRefPubMedPubMedCentral
37.
go back to reference Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J: Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?. Hepatology. 2002, 36: 403-409. 10.1053/jhep.2002.34738.CrossRefPubMed Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J: Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?. Hepatology. 2002, 36: 403-409. 10.1053/jhep.2002.34738.CrossRefPubMed
38.
go back to reference Yang R, Barouch LA: Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007, 101: 545-559. 10.1161/CIRCRESAHA.107.156596.CrossRefPubMed Yang R, Barouch LA: Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007, 101: 545-559. 10.1161/CIRCRESAHA.107.156596.CrossRefPubMed
40.
go back to reference Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW: A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012, 153: 5782-5795. 10.1210/en.2012-1595.CrossRefPubMed Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW: A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012, 153: 5782-5795. 10.1210/en.2012-1595.CrossRefPubMed
41.
go back to reference Mazella J, Béraud-Dufour S, Devader C, Massa F, Coppola T: Neurotensin and its receptors in the control of glucose homeostasis. Front Endocrinol (Lausanne). 2012, 3: 143- Mazella J, Béraud-Dufour S, Devader C, Massa F, Coppola T: Neurotensin and its receptors in the control of glucose homeostasis. Front Endocrinol (Lausanne). 2012, 3: 143-
42.
go back to reference Assimakopoulos SF, Tsamandas AC, Georgiou CD, Vagianos CE, Scopa CD: Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver. Peptides. 2010, 31: 2294-2303. 10.1016/j.peptides.2010.09.003.CrossRefPubMed Assimakopoulos SF, Tsamandas AC, Georgiou CD, Vagianos CE, Scopa CD: Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver. Peptides. 2010, 31: 2294-2303. 10.1016/j.peptides.2010.09.003.CrossRefPubMed
43.
go back to reference Pacher P, Bátkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006, 58: 389-462. 10.1124/pr.58.3.2.CrossRefPubMedPubMedCentral Pacher P, Bátkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006, 58: 389-462. 10.1124/pr.58.3.2.CrossRefPubMedPubMedCentral
44.
go back to reference Zhao W, Fong O, Muise ES, Thompson JR, Weingarth D, Qian S, Fong TM: Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Mol Pharmacol. 2010, 78: 350-359. 10.1124/mol.110.064980.CrossRefPubMed Zhao W, Fong O, Muise ES, Thompson JR, Weingarth D, Qian S, Fong TM: Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Mol Pharmacol. 2010, 78: 350-359. 10.1124/mol.110.064980.CrossRefPubMed
45.
go back to reference Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, Vettor R: The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab. 2007, 92: 4810-4819. 10.1210/jc.2007-0768.CrossRefPubMed Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, Vettor R: The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab. 2007, 92: 4810-4819. 10.1210/jc.2007-0768.CrossRefPubMed
46.
go back to reference Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, Innis RB, Cheng K, Rice KC, Deschamps JR, Chorvat RJ, McElroy JF, Kunos G: Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab. 2012, 16: 167-179. 10.1016/j.cmet.2012.07.002.CrossRefPubMed Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, Innis RB, Cheng K, Rice KC, Deschamps JR, Chorvat RJ, McElroy JF, Kunos G: Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab. 2012, 16: 167-179. 10.1016/j.cmet.2012.07.002.CrossRefPubMed
47.
go back to reference Aller R, de Luis DA, Pacheco D, Velasco MC, Conde R, Izaola O, González Sagrado M: Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. Nutr Hosp. 2012, 27: 1637-1642.PubMed Aller R, de Luis DA, Pacheco D, Velasco MC, Conde R, Izaola O, González Sagrado M: Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. Nutr Hosp. 2012, 27: 1637-1642.PubMed
48.
go back to reference Izzo AA, Camilleri M: Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008, 57: 1140-1155. 10.1136/gut.2008.148791.CrossRefPubMed Izzo AA, Camilleri M: Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008, 57: 1140-1155. 10.1136/gut.2008.148791.CrossRefPubMed
49.
go back to reference Czyzyk TA, Romero-Picó A, Pintar J, McKinzie JH, Tschöp MH, Statnick MA, Nogueiras R: Mice lacking δ-opioid receptors resist the development of diet-induced obesity. FASEB J. 2012, 26: 3483-3492. 10.1096/fj.12-208041.CrossRefPubMedPubMedCentral Czyzyk TA, Romero-Picó A, Pintar J, McKinzie JH, Tschöp MH, Statnick MA, Nogueiras R: Mice lacking δ-opioid receptors resist the development of diet-induced obesity. FASEB J. 2012, 26: 3483-3492. 10.1096/fj.12-208041.CrossRefPubMedPubMedCentral
50.
go back to reference Matsunaga M, Isowa T, Murakami H, Kasugai K, Yoneda M, Kaneko H, Ohira H: Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception. Brain Behav Immun. 2009, 23: 931-935. 10.1016/j.bbi.2009.03.007.CrossRefPubMed Matsunaga M, Isowa T, Murakami H, Kasugai K, Yoneda M, Kaneko H, Ohira H: Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception. Brain Behav Immun. 2009, 23: 931-935. 10.1016/j.bbi.2009.03.007.CrossRefPubMed
Metadata
Title
Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease
Authors
Rohini Mehta
Aybike Birerdinc
Lei Wang
Zahra Younoszai
Amir Moazzez
Hazem Elariny
Zachary Goodman
Vikas Chandhoke
Ancha Baranova
Zobair M Younossi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2014
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-14-72

Other articles of this Issue 1/2014

BMC Gastroenterology 1/2014 Go to the issue